questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Inflammation
Suppuration
Empyème
Empyème pleural
Empyème pleural : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Empyème pleural : Questions médicales les plus fréquentes",
"headline": "Empyème pleural : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Empyème pleural : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-25",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Empyème pleural"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Empyème",
"url": "https://questionsmedicales.fr/mesh/D004653",
"about": {
"@type": "MedicalCondition",
"name": "Empyème",
"code": {
"@type": "MedicalCode",
"code": "D004653",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.470.756.305"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Empyème tuberculeux",
"alternateName": "Empyema, Tuberculous",
"url": "https://questionsmedicales.fr/mesh/D004654",
"about": {
"@type": "MedicalCondition",
"name": "Empyème tuberculeux",
"code": {
"@type": "MedicalCode",
"code": "D004654",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.470.756.305.250.320"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Empyème pleural",
"alternateName": "Empyema, Pleural",
"code": {
"@type": "MedicalCode",
"code": "D016724",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Cheng-Li Lin",
"url": "https://questionsmedicales.fr/author/Cheng-Li%20Lin",
"affiliation": {
"@type": "Organization",
"name": "Management Office for Health Data, China Medical University Hospital , Taichung, Taiwan."
}
},
{
"@type": "Person",
"name": "Te-Chun Shen",
"url": "https://questionsmedicales.fr/author/Te-Chun%20Shen",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, No. 2, Yude Road, Taichung, 404, Taiwan."
}
},
{
"@type": "Person",
"name": "Danail B Petrov",
"url": "https://questionsmedicales.fr/author/Danail%20B%20Petrov",
"affiliation": {
"@type": "Organization",
"name": "Medical University - Sofia, Sofia, Bulgaria."
}
},
{
"@type": "Person",
"name": "Dragan Subotic",
"url": "https://questionsmedicales.fr/author/Dragan%20Subotic",
"affiliation": {
"@type": "Organization",
"name": "University Hospital Basel, Basel, Switzerland."
}
},
{
"@type": "Person",
"name": "Georgi S Yankov",
"url": "https://questionsmedicales.fr/author/Georgi%20S%20Yankov",
"affiliation": {
"@type": "Organization",
"name": "Medical University - Sofia, Sofia, Bulgaria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Primary Sclerosing Cholangitis: Epidemiology, Diagnosis, and Presentation.",
"datePublished": "2023-08-21",
"url": "https://questionsmedicales.fr/article/37945154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cld.2023.07.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recent Advances in the Management of Primary Sclerosing Cholangitis.",
"datePublished": "2023-04-19",
"url": "https://questionsmedicales.fr/article/37084929",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cgh.2023.04.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "EASL Clinical Practice Guidelines on sclerosing cholangitis.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35738507",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jhep.2022.05.011"
}
},
{
"@type": "ScholarlyArticle",
"name": "Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports.",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37106413",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13256-023-03908-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patient-reported quality of care in primary sclerosing cholangitis.",
"datePublished": "2023-06-13",
"url": "https://questionsmedicales.fr/article/37312635",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/liv.15650"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Inflammation",
"item": "https://questionsmedicales.fr/mesh/D007249"
},
{
"@type": "ListItem",
"position": 5,
"name": "Suppuration",
"item": "https://questionsmedicales.fr/mesh/D013492"
},
{
"@type": "ListItem",
"position": 6,
"name": "Empyème",
"item": "https://questionsmedicales.fr/mesh/D004653"
},
{
"@type": "ListItem",
"position": 7,
"name": "Empyème pleural",
"item": "https://questionsmedicales.fr/mesh/D016724"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Empyème pleural - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Empyème pleural",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Empyème pleural",
"description": "Comment diagnostique-t-on un empyème pleural ?\nQuels tests sont utilisés pour confirmer un empyème ?\nQuels signes cliniques indiquent un empyème ?\nL'imagerie est-elle toujours nécessaire ?\nPeut-on confondre un empyème avec une autre condition ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Cholangitis,+Sclerosing&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Empyème pleural",
"description": "Quels sont les symptômes principaux d'un empyème ?\nL'empyème provoque-t-il des douleurs ?\nY a-t-il des symptômes systémiques associés ?\nLes symptômes varient-ils selon l'âge ?\nUn empyème peut-il être asymptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Cholangitis,+Sclerosing&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Empyème pleural",
"description": "Comment prévenir un empyème pleural ?\nLes vaccinations aident-elles à prévenir l'empyème ?\nY a-t-il des mesures d'hygiène à respecter ?\nLes personnes âgées sont-elles plus à risque ?\nLe traitement des maladies chroniques aide-t-il ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Cholangitis,+Sclerosing&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Empyème pleural",
"description": "Quel est le traitement principal de l'empyème ?\nDes antibiotiques sont-ils nécessaires ?\nQuand une intervention chirurgicale est-elle requise ?\nLe traitement est-il différent chez les enfants ?\nQuels soins de suivi sont nécessaires après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Cholangitis,+Sclerosing&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Empyème pleural",
"description": "Quelles sont les complications possibles d'un empyème ?\nL'empyème peut-il entraîner des séquelles ?\nComment prévenir les complications ?\nLes complications sont-elles fréquentes ?\nQuelles sont les conséquences d'une septicémie liée à un empyème ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Cholangitis,+Sclerosing&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Empyème pleural",
"description": "Quels sont les principaux facteurs de risque d'empyème ?\nLes antécédents médicaux influencent-ils le risque ?\nLe système immunitaire joue-t-il un rôle ?\nLes conditions de vie affectent-elles le risque ?\nLes maladies pulmonaires chroniques sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Cholangitis,+Sclerosing&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un empyème pleural ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par imagerie (radiographie, échographie) et analyse du liquide pleural."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer un empyème ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une thoracocentèse permet d'analyser le liquide pleural pour confirmer l'infection."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un empyème ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur thoracique, dyspnée et toux productive sont des signes fréquents."
}
},
{
"@type": "Question",
"name": "L'imagerie est-elle toujours nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'imagerie est essentielle pour évaluer l'étendue de l'empyème et guider le traitement."
}
},
{
"@type": "Question",
"name": "Peut-on confondre un empyème avec une autre condition ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec une pneumonie ou un abcès pulmonaire sans analyse précise."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux d'un empyème ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, douleur thoracique et essoufflement."
}
},
{
"@type": "Question",
"name": "L'empyème provoque-t-il des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur thoracique est fréquente, souvent aggravée par la respiration ou la toux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme fatigue, malaise général et perte d'appétit peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent présenter des symptômes moins spécifiques que les adultes."
}
},
{
"@type": "Question",
"name": "Un empyème peut-il être asymptomatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, un empyème peut être asymptomatique, surtout à ses débuts."
}
},
{
"@type": "Question",
"name": "Comment prévenir un empyème pleural ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par le traitement rapide des infections pulmonaires et des maladies sous-jacentes."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir l'empyème ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations contre la pneumonie peuvent réduire le risque d'empyème."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures d'hygiène à respecter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et éviter le tabagisme peuvent aider à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru d'empyème en raison de leur santé générale."
}
},
{
"@type": "Question",
"name": "Le traitement des maladies chroniques aide-t-il ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon contrôle des maladies chroniques peut réduire le risque d'empyème."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de l'empyème ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est le drainage du liquide pleural, souvent par thoracocentèse."
}
},
{
"@type": "Question",
"name": "Des antibiotiques sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques sont prescrits pour traiter l'infection sous-jacente."
}
},
{
"@type": "Question",
"name": "Quand une intervention chirurgicale est-elle requise ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention chirurgicale est nécessaire si le drainage ne suffit pas ou en cas de complications."
}
},
{
"@type": "Question",
"name": "Le traitement est-il différent chez les enfants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est similaire, mais les doses et les approches peuvent varier selon l'âge."
}
},
{
"@type": "Question",
"name": "Quels soins de suivi sont nécessaires après traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est essentiel pour surveiller la guérison et prévenir les récidives."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'un empyème ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la fibrose pleurale, l'insuffisance respiratoire et la septicémie."
}
},
{
"@type": "Question",
"name": "L'empyème peut-il entraîner des séquelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles comme des douleurs thoraciques chroniques ou des limitations respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et approprié de l'empyème est essentiel pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent survenir, surtout si l'empyème n'est pas traité rapidement."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une septicémie liée à un empyème ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La septicémie peut entraîner un choc septique, des défaillances d'organes et un risque de mortalité."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'empyème ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections pulmonaires, le tabagisme et les maladies chroniques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de pneumonie ou de chirurgie thoracique augmentent le risque d'empyème."
}
},
{
"@type": "Question",
"name": "Le système immunitaire joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un système immunitaire affaibli augmente le risque d'infections et d'empyème."
}
},
{
"@type": "Question",
"name": "Les conditions de vie affectent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions de vie précaires ou surpeuplées peuvent augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les maladies pulmonaires chroniques sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la BPCO augmentent le risque d'empyème en raison de l'inflammation."
}
}
]
}
]
}
Primary sclerosing cholangitis (PSC) is considered an immunologically mediated disease. However, some of its features are not consistent with the typical profile of autoimmune conditions. PSC is chara...
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by fibroinflammatory damage to the biliary tree, typically in the setting of inflammatory bowel disease, with ...
Management of primary or secondary sclerosing cholangitis is challenging. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics including diagnostic me...
Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis is an extremely rare condition that has been reported in only few published cases so far in the literature. We h...
We report two cases showing the manifestations of both primary biliary cholangitis and primary sclerosing cholangitis in two Tunisian female patients aged 74 and 42 years, respectively. The first case...
Our cases raise awareness for this rare condition and indicate the importance of recognizing a possible overlap syndrome, especially in patients with primary biliary cholangitis, to optimize treatment...
Management and follow-up strategies for primary sclerosing cholangitis (PSC) vary. The aim of the present study was to assess patient-reported quality of care to identify the most important areas for ...
Data were collected via an online survey hosted on the EU Survey platform in 11 languages between October 2021 and January 2022. Questions were asked about the disease, symptoms, treatment, investigat...
In total, 798 nontransplanted people with PSC from 33 countries responded. Eighty-six per cent of respondents reported having had at least one symptom. Twenty-four per cent had never undergone an elas...
Symptom burden in PSC is high, and the most important areas of improvement are disease monitoring with more widespread use of elastography, bone density scan and appropriate treatment for itch. Person...
Primary sclerosing cholangitis (PSC) offers unique opportunities to explore the gut-liver axis owing to the close association between liver disease and colonic inflammation. It is well established tha...
Secondary sclerosing cholangitis (SSC) is a progressive disease with high mortality and characterized by chronic inflammation and biliary obstruction. Therapeutic options are limited. The aim of this ...
Data from all patients with SSC from 1996 to April 2021 were included....
Eighty patients with SSC were included. Seventy-five patients (93.8%) underwent diagnostic endoscopic retrograde cholangiography; 46 patients (57.5%) could be treated endoscopically. Endoscopic treatm...
Secondary sclerosing cholangitis is a progressive disease with poor long-term prognosis. Endoscopic treatment options seem to be limited regarding transplantation-free survival but might improve quali...
Cholangiocarcinoma (CCA) is a deadly complication observed in the setting of primary sclerosing cholangitis (PSC). When symptoms develop and CCA is diagnosed, it is usually at an advanced stage. Media...
Primary sclerosing cholangitis (PSC) is notoriously challenging to manage given its heterogeneity with regard to diagnosis, management, and progression. The lack of disease-modifying therapy and varia...
We conducted a systematic literature review to understand the evidence supporting treatment decisions for cholestatic pruritus associated with primary biliary cholangitis (PBC) and primary sclerosing ...
Studies that enrolled ≥ 75% participants with PBC or PSC and reported ≥ 1 endpoint(s) related to efficacy, safety, health-related quality of life (HRQoL) or other patient-reported outcomes were includ...
Thirty-nine publications were identified, covering 42 studies and six treatment classes (including investigational and approved products): anion-exchange resins, antibiotics (rifampicin/derivatives), ...
There is a lack of consistent and reproducible evidence available on efficacy, impact on HRQoL, and safety of cholestatic pruritus treatments, leaving physicians to rely on clinical experience rather ...